NCR Voyix Valuation

Is VYX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VYX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VYX ($14.67) is trading below our estimate of fair value ($21.8)

Significantly Below Fair Value: VYX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for VYX?

Key metric: As VYX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for VYX. This is calculated by dividing VYX's market cap by their current revenue.
What is VYX's PS Ratio?
PS Ratio0.6x
SalesUS$3.59b
Market CapUS$2.22b

Price to Sales Ratio vs Peers

How does VYX's PS Ratio compare to its peers?

The above table shows the PS ratio for VYX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.7x
BLND Blend Labs
8x19.5%US$1.3b
VRNT Verint Systems
2x6.8%US$1.9b
HUT Hut 8
13.2x46.2%US$2.6b
BTDR Bitdeer Technologies Group
7.8x43.8%US$3.1b
VYX NCR Voyix
0.6x-23.2%US$2.2b

Price-To-Sales vs Peers: VYX is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (8x).


Price to Sales Ratio vs Industry

How does VYX's PS Ratio compare vs other companies in the US Software Industry?

80 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.5.8x12.5%
VYX NCR Voyix
0.6x-23.2%US$2.22b
PGY Pagaya Technologies
0.7x15.8%US$698.26m
XPER Xperi
0.9x1.8%US$467.58m
VYX 0.6xIndustry Avg. 5.8xNo. of Companies80PS048121620+
80 CompaniesEstimated GrowthMarket Cap
Industry Avg.5.8x16.9%
VYX NCR Voyix
0.6x113.1%US$2.22b
No more companies

Price-To-Sales vs Industry: VYX is good value based on its Price-To-Sales Ratio (0.6x) compared to the US Software industry average (5.8x).


Price to Sales Ratio vs Fair Ratio

What is VYX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VYX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: VYX is expensive based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VYX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$14.67
US$18.44
+25.7%
20.0%US$28.00US$15.00n/a9
Dec ’25US$14.51
US$18.22
+25.6%
21.0%US$28.00US$14.00n/a9
Nov ’25US$12.78
US$18.00
+40.8%
21.8%US$28.00US$14.00n/a9
Oct ’25US$13.34
US$18.50
+38.7%
20.9%US$28.00US$16.00n/a8
Sep ’25US$13.49
US$18.50
+37.1%
20.9%US$28.00US$16.00n/a8
Aug ’25US$14.21
US$18.78
+32.1%
20.2%US$28.00US$14.00n/a9
Jul ’25US$12.60
US$18.78
+49.0%
20.2%US$28.00US$14.00n/a9
Jun ’25US$13.18
US$19.13
+45.1%
20.3%US$28.00US$14.00n/a8
May ’25US$12.13
US$19.64
+61.9%
19.6%US$28.00US$14.00n/a9
Apr ’25US$12.37
US$19.78
+59.9%
19.6%US$28.00US$14.00n/a9
Mar ’25US$11.47
US$22.00
+91.8%
13.7%US$28.00US$19.00n/a7
Feb ’25US$15.18
US$21.33
+40.5%
8.8%US$24.00US$19.00n/a6
Jan ’25US$16.91
US$21.40
+26.6%
9.6%US$24.00US$19.00n/a5
Dec ’24US$16.14
US$21.25
+31.7%
10.7%US$24.00US$19.00US$14.514
Nov ’24US$15.58
US$22.00
+41.2%
9.8%US$24.00US$19.00US$12.783
Oct ’24US$26.97
US$33.00
+22.4%
12.7%US$40.00US$28.00US$13.345
Sep ’24US$30.70
US$32.71
+6.6%
11.4%US$40.00US$28.00US$13.497
Aug ’24US$26.36
US$31.57
+19.8%
10.1%US$37.00US$26.00US$14.217
Jul ’24US$25.20
US$31.88
+26.5%
9.7%US$37.00US$26.00US$12.608
Jun ’24US$24.00
US$31.88
+32.8%
9.7%US$37.00US$26.00US$13.188
May ’24US$21.98
US$31.75
+44.4%
10.5%US$37.00US$25.00US$12.138
Apr ’24US$23.59
US$31.75
+34.6%
10.5%US$37.00US$25.00US$12.378
Mar ’24US$25.58
US$31.75
+24.1%
10.5%US$37.00US$25.00US$11.478
Feb ’24US$28.07
US$29.88
+6.4%
11.9%US$35.00US$24.00US$15.188
Jan ’24US$23.41
US$29.88
+27.6%
11.9%US$35.00US$24.00US$16.918
Dec ’23US$23.77
US$29.38
+23.6%
11.9%US$35.00US$24.00US$16.148

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies